The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
1 | Details of the person discharging managerial responsibilities/person closely associated |
|||
a) | Name | David Ebsworth |
||
2 | Reason for the notification |
|||
a) | Position/status | Non-Executive Chairman |
||
b) | Initial notification/Amendment | Initial notification |
||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||
a) | Name | Verona Pharma plc |
||
b) | LEI | 213800EVI6O6J3TIAL06 |
||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
a) | Description of the financial instrument, type of instrument |
Ordinary Shares of 5 pence each |
||
Identification code | GB00BYW2KH80 | |||
b) | Nature of the transaction | David Ebsworth purchased 10,000 Ordinary Shares | ||
c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
106.85 pence per Ordinary Share | 10,000 Ordinary Shares | |||
d) | Aggregated information | N/A |
||
- Aggregated volume | ||||
- Price | ||||
e) | Date of the transaction | 29 November 2017 | ||
f) | Place of the transaction | London Stock Exchange, AIM |
||
For further information, please contact:
Verona Pharma plc | Tel: +44 (0)20 3283 4200 |
Jan-Anders Karlsson, Chief Executive Officer | info@veronapharma.com |
Stifel Nicolaus Europe Limited (Nominated Adviser and UK Broker) |
Tel: +44 (0) 20 7710 7600 SNELVeronaPharma@stifel.com |
Stewart Wallace / Jonathan Senior / Ben Maddison |
Source: Verona Pharma plc
For further information please contact:
Verona Pharma plc
Jan-Anders Karlsson, CEO
Tel: +44 (0)20 3283 4200
info@veronapharma.com
Stifel Nicolaus Europe Ltd (Nominated Adviser and UK Broker)
Jonathan Senior / Stewart Wallace
Tel: +44 (0)20 7710 7600
FTI Consulting
Simon Conway / Natalie Garland-Collins
Tel: +44 (0)20 3727 1000
veronapharma@fticonsulting.com
ICR, Inc. (US Media and Investor enquiries)
James Heins
Tel: +1 203-682-8251
James.Heins@icrinc.com
Stephanie Carrington
Tel. +1 646-277-1282
Stephanie.Carrington@icrinc.com